Please complete the CAPTCHA to continue
@lexariabioscience.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
John Docherty is listed as President and Head of Research at Lexaria Bioscience at Lexaria Bioscience, a company with 4 employees, based in Greater Toronto Area, Canada, Canada. AeroLeads shows a work email signal at lexariabioscience.com and a matched LinkedIn profile for John Docherty.
John Docherty previously worked as President and Head of Research at Lexaria Bioscience and Principal at Docherty Management Limited. John Docherty holds Master Of Science (M.Sc.), Pharmacology from University Of Toronto.
This section adds company-level context without repeating John Docherty's masked contact details.
AeroLeads found 1 current-domain work email signal for John Docherty. Compare company email patterns before reaching out.
An accomplished, action-oriented leader who thrives on advancing Canadian technology and innovation.
Listed skills include Pharmaceutical Development, Regulatory Affairs, Stakeholder Communications, Strategic Planning, and 31 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Canada
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms designed for the consumer packaged goods and pharmaceutical industries. Its patented DehydraTECH™ drug delivery platform technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier administration methods both orally and topically, lower.
Durham Region, Ontario
Docherty Management Ltd. is a limited liability corporation that provides strategic and advisory management services to clinical-stage biopharmaceutical and pharmaceutical companies. Clients include companies developing novel drug products for a variety of therapeutic indications, with an emphasis in pain management, neurodegenerative disorders and.
Aurora, Ontario
Helix is a publicly listed (TSX, FSE: “HBP”), clinical-stage, biopharmaceutical company focused on the development of biologically-derived, protein therapeutics for the treatment and prevention of cancer. At Helix, Mr. Docherty was a key spokesperson for the Company and provided leadership in the areas listed below. Mr. Docherty also served as a management.
Saskatoon, Saskatchewan
PharmaDerm was a university spin-off drug delivery company that became a wholly owned subsidiary of Helix BioPharma in 1997 and was later rolled into Helix as a division in 2008. Mr. Docherty became President of PharmaDerm in 2004, where he led a team of 15 researchers in a state-of-the art formulation development, testing and small scale biopharmaceutical.
Aurora, Ontario
In this capacity, Mr. Docherty was instrumental in developing and maintaining a key strategic partnership for Helix BioPharma Corp; a license option agreement that was valued at $23.25M in license fees plus an estimated $70M in prospective annual royalties. He also negotiated the sale of Helix’s international commercial rights for Klean Prep™ to a leading.
Toronto, Ontario
PriceWaterhouseCoopers is one of the world’s largest professional services firms. Its former global pharmaceutical industry practice provided expert consulting services in business strategy, strategic alliance development, organizational strategy, product development, and financial and cost management. At PriceWaterhouseCoopers, Mr. Docherty executed on.
Richmond Hill, Ontario
Nu-Pharm was a former subsidiary of Apotex Inc., specialized in the development of generic and brand name, sterile and non-sterile solution pharmaceuticals. At Nu-Pharm, Mr. Docherty was responsible for designing and implementing the Company’s U.S. regulatory affairs capability. He built this skill set within the regulatory affairs department in the.
Mississauga, Ontario
Astra Pharma Inc. (now AstraZeneca) is a world-class innovative pharmaceutical company. At Astra, Mr. Docherty was a member of a team of regulatory affairs professionals who prepared new drug submissions for commercial authorizations in Canada and internationally. He focused primarily on cardiac and respiratory therapies.
Other employees you can reach at lexariabioscience.com. View company contacts for 4 employees →
Quick answers generated from the profile data available on this page.
John Docherty works for Lexaria Bioscience.
John Docherty is listed as President and Head of Research at Lexaria Bioscience at Lexaria Bioscience.
AeroLeads has found 1 work email signal at @lexariabioscience.com for John Docherty at Lexaria Bioscience.
John Docherty is based in Greater Toronto Area, Canada, Canada while working with Lexaria Bioscience.
John Docherty has worked for Lexaria Bioscience, Docherty Management Limited, Helix Biopharma Corporation, Pharmaderm Laboratories Ltd., and Helix Biopharma Corp..
John Docherty's colleagues at Lexaria Bioscience include Jessica Bauer, Vanessa Carle, and George Jurčić.
You can use AeroLeads to view verified contact signals for John Docherty at Lexaria Bioscience, including work email, phone, and LinkedIn data when available.
John Docherty holds Master Of Science (M.Sc.), Pharmacology from University Of Toronto.
John Docherty is listed with skills including Pharmaceutical Development, Regulatory Affairs, Stakeholder Communications, Strategic Planning, Process Improvement, Establishing Strategic Partnerships, Vendor Management, and Oral And Written Communication Skills.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the John Docherty you were looking for.
